Plasmid-DNA loaded chitosan microspheres for in vitro IL-2 expression

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 58, Issue 3, 2004, Pages 501-507

  Akbuǧa, Jülide ^a   Özbaş Turan, Suna ^a   Erdoǧan, Neslihan ^b  

^a MARMARA UNIVERSITY   (Turkey)

^b Roche Pharm Comp   (Turkey)

Author keywords

Chitosan; Gene delivery; Gene therapy; In vitro transfection; Interleukin 2; Microspheres; Plasmid DNA

Indexed keywords

CHITOSAN; GLUTARALDEHYDE; INTERLEUKIN 2; LIPOFECTIN; MICROSPHERE; PLASMID DNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE TARGETING; GENETIC CODE; GENETIC TRANSFECTION; IMMUNOTHERAPY; MALE; MICROENCAPSULATION; MOLECULAR WEIGHT; NONHUMAN; PRECIPITATION; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RAT; ZETA POTENTIAL;

ANIMALS; CELL LINE, TUMOR; CHITOSAN; DNA; GENE EXPRESSION REGULATION; INTERLEUKIN-2; MICROSPHERES; PLASMIDS; RATS;

EID: 4644342375     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2004.04.015     Document Type: Article

References (24)

1. Lotze M.T., Frana L.W., Sharrow S.O., Robb R.J., Rosenberg S.A. In vivo administration of purified human interleukin-2. Half life and immunologic effects of Jurkat cell-line derived interleukin-2. J. Immunol. 134:1985;157-166
2. Belldegrun A., Tso C.-L., Zisman A., Naitoh J., Said J., Pantuck A.J., Hinkel A., DeKernion J., Figlin R. Interleukin-2 gene therapy for prostate cancer: phase I clinical trial and basic biology. Hum. Gene. Ther. 12:2001;883-892
3. Prud'homme G.J., Lawson B.K., Chang Y., Theofitopoulos A.V. Immuno-therapeutic gene transfer into muscle. Trends. Immunol. 22:2001;149-155
4. Jiang J., Yamato E., Miyazaki J. Intravenous delivery of naked plasmid DNA for in vivo cytokine expression. Biochem. Biophys. Res. Commun. 289:2002;1088-1092
5. Addison C.L., Braciak T., Ralston R., Müller W.J., Gauldie J., Graham F.L. Intratumoral injection of an adenovirus expressing interleukin-2 induced regression and immunity in a murine breast cancer model. Proc. Natl. Acad. Sci. USA. 92:1995;8522-8526
6. Hoffman D.M., Figlin R.A. Intratumoral interleukin-2 for renal-cell carcinoma by direct gene transfer of a plasmid DNA/DMRIE/DOPE lipid complex. World J. Urol. 18:2000;152-156
7. Oh Y.K., Suh D., Kim J.M., Choi H.-G., Skin K., Ko J.J. Polyethyleneimine-mediated cellular uptake, nucleus traficking and expression of cytokine plasmid DNA. Gene Ther. 9:2002;1627-1632
8. Erbacher P., Zou S., Bethinger T., Steffan A.M., Remy J.S. Chitosan based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability. Pharm. Res. 15:1998;1332-1339
9. Leong K.W., Mao H.Q., Truong-Le V.L., Roy K., Walsh S.M., August J.T. DNA-polycation nanospheres as non-viral gene delivery vehicles. J. Cont. Rel. 53:1998;183-193
10. Ishii T., Okayata Y., Sato T. Mechanism of cell transfection with plasmid/chitosan complex. Biochim. Biophys. Acta. 1514:2001;51-64
11. Özbaş-Turan S., Aral C., Kabasakal L., Keyer-Uysal M., Akbuga J. Co-encapsulation of two plasmids in chitosan microspheres as a non-viral gene delivery vehicle. J. Pharm. Pharmaceu. Sci. 6:2003;27-32
12. Akbuga J., Aral C., Özbaş-Turan S., Kabasakal L., Keyer-Uysal M. Transfection efficiency of chitosan microspheres: effect of DNA topology. S.T.P. Pharm. Sci. 13:2003;99-103
13. Niwa H., Yamamura K.-I., Miyazaki J.-I. Efficient selection for high-expression transfectans with a novel eucaryotic vector. Gene. 108:1991;193-199
14. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: a Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, New York
15. Berthold A., Cremer K., Kreuter J. Preparation and characterization of chitosan microspheres as drug carriers for prednisolone sodium phosphate as model for anti inflammatory drugs. J. Cont. Rel. 39:1996;17-25
16. Aral C., Özbaş-Turan S., Kabasakal L., Keyer-Uysal M., Akbuga J. Studies of effective factors of plasmid DNA-loaded chitosan microspheres: I. Plasmid size, chitosan concentration and plasmid addition techniques. S.T.P. Pharm. Sci. 10:2000;83-88
17. Mao H.-Q., Roy K., Troung-Le V.L., Janes K.A., Lin K.Y., Wang Y., August J.T., Leong K.W. Chitosan-DNA nanoparticles as gene carriers: synthesis characterization and transfection efficiency. J. Cont. Rel. 70:2001;399-421
18. Ando S., Putnam D., Pack D.W., Langer R. PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization. J. Pharm. Sci. 88:(1):1999;126-130
19. Jong Y.S., Jacob J.S., Yip K.-P., Gardner G., Seitelman E., Whitney M., Montgomery S., Mathiowitz E. Controlled release of plasmid DNA. J. Cont. Rel. 47:1997;123-134
20. Xu Y., Du Y. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int. J. Pharm. 250:2003;215-226
21. Truong-Le V.L., August J.T., Leong K.W. Controlled gene delivery DNA-gelatin nanospheres. Hum. Gene Ther. 9:1998;1709-1717
22. Huang M., Ma Z., Khor E., Lim L.-Y. Uptake of FITC-chitosan nanoparticles by A549 cells. Pharm. Res. 19:2002;1488-1494
23. Chapple I.L. Reactive oxygen species and antioxidants in inflammatory diseases. J. Clin. Periodontol. 24:1997;287-296
24. Chandiere J., Ferrari-Illion R. Intracellular antioxidants: from chemical to biochemical mechanisms. Food Chem. Toxicol. 37:1999;949-962